PAG
ELDN icon

Private Advisor Group’s Eledon Pharmaceuticals ELDN Stock Holding History

Private Advisor Group’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$85.7K Buy
+21,760
New +$79.1K ﹤0.01% 2447
2020
Q3 		– Sell
-6
Closed – – 2085
2020
Q2 		$0 Buy
+6
New +$68 ﹤0.01% 3858

Other funds holding ELDN

TCM
Triumph Capital Management Denver, Colorado $552M AUM 20.75% 1-Year Est. Return
PAM
Prodigy Asset Management Omaha, Nebraska $332M AUM 10.57% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return
PNFS
PW Nova Financial Services Newtown, Pennsylvania $466M AUM
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
HFS
Howard Financial Services Dallas, Texas $1B AUM 20.02% 1-Year Est. Return
KPWS
Kestra Private Wealth Services Austin, Texas $9.1B AUM 32.09% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
RZH
Relyea Zuckerberg Hanson Stamford, Connecticut $1.2B AUM 28.45% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Private Advisor Group's ELDN Position: Q2 2026 in Review

Private Advisor Group opened a new position in Eledon Pharmaceuticals (ELDN) in Q2 2026: 21,760 shares worth $85.7K. The stake represents ﹤0.01% of the portfolio and ranks #2447 among its holdings. This is a return to the name: Private Advisor Group previously reported a position in ELDN as recently as Q2 2020.

Private Advisor Group first reported a position in ELDN in Q2 2020 and has held it in 2 quarters since. 38 funds tracked by Wall St. Rank hold ELDN as of Q2 2026.

  • Private Advisor Group held 21,760 shares of Eledon Pharmaceuticals worth $85.7K as of Q2 2026.
  • Eledon Pharmaceuticals was a new Private Advisor Group position in Q2 2026.
  • Eledon Pharmaceuticals made up ﹤0.01% of Private Advisor Group's portfolio in Q2 2026, its #2447 holding.
  • Private Advisor Group first reported a position in Eledon Pharmaceuticals in Q2 2020 and has held it in 2 quarters since.
  • 38 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q2 2026.

Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.